Morphine-6β-glucuronide modulates the expression of inducible nitric oxide synthase

Inflammation

Volumn 25, Issue 4, 2001, Pages 267-275

  Lysle, Donald T ^a,b   Carrigan, Kelly A ^a  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Lipopolysaccharide; Morphine 6 glucuronide; Naltrexone; Nitric oxide

Indexed keywords

LIPOPOLYSACCHARIDE; MORPHINE 6 GLUCURONIDE; NALTREXONE; NITRATE; NITRIC OXIDE SYNTHASE; NITRITE; OPIATE RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; MORPHINE DERIVATIVE; MORPHINE-6-GLUCURONIDE; NARCOTIC ANTAGONIST; NOS2 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; IMMUNOREGULATION; LIVER; LUNG; MALE; NONHUMAN; RAT; SPLEEN; TISSUE DISTRIBUTION; ANIMAL; BLOOD; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; LEWIS RAT; METABOLISM;

ANIMALIA;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; LIPOPOLYSACCHARIDES; LIVER; LUNG; MALE; MORPHINE DERIVATIVES; NALTREXONE; NARCOTIC ANTAGONISTS; NITRATES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, INBRED LEW; SPLEEN; TISSUE DISTRIBUTION;

EID: 0034741776     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010924320902     Document Type: Article

References (67)

1. Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway
2. Immunosuppression induced by nitric oxide and its inhibition by interleukin-4
3. Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism
4. Suppression of natural killer cell activity by high dose narcotic anesthesia in rats
5. Role of nitric oxide in the failure of neutrophil migration in sepsis
6. Extrahepatic morphine metabolism in man during the anhepatic phase of orthotopic liver transplanation
7. The metabolism of morphine and heroin in man
8. Immunologic dysfunction in morphine-6-glucuronide addicts
9. Morphine pellet-induced immunomodulation in mice: Temporal relationships
10. Mu receptor binding of some commonly used opioids and their metabolites
11. The dual personality of NO
12. The enantioselective glucuronidation of morphine in rats and humans: Evidence for the involvement of more than one UDP-glucuronosyltransferase isoenzyme
13. Coordinate and independent effects of morphine-6-glucuronide, cocaine and alcohol abuse on T-cell E-rosette formation and antigenic marker expression
14. Macrophage nitric oxide mediates immunosuppression in infectious inflammation
15. Comparison of the discriminative and antinociceptive effects of morphine and its glucuronide metabolites after central or systemic administration in the rat
16. Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain
17. Evidence for β-adrenergic receptor involvement in the immunomodulatory effects of morphine
18. Heroin-Induced alterations in Leukocyte Numbers and Apoptosis in the Rat Spleen
19. Macrophage-derived nitric oxide is involved in the depressed Con A-responsiveness of splenic lymphocytes from rats administered morphine in-vivo
20. Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats
21. Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats
22. Alterations of immune functions in morphine-6-glucuronide addicts and morphine-6-glucuronide withdrawal subjects
23. Antimicrobial and immunopathologic effect of cytokine-induced nitric oxide synthesis
24. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism
25. 15N]nitrate in biological fluids
26. Resolution of acute inflammation and the role of apoptosis in tissue fate of graulocytes
27. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia
28. Morphine: Pharmacokinetics and clinical practice
29. Interferon inhibition by narcotic analgesics
30. Infections resulting rom narcotic addiction: Report of 102 cases
31. Opioids inhibit the induction of nitric oxide synthase in J774 macrophages
32. Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates
33. Potency ratios of morphine and morphine-6β-glucuronide analgesia elicited from the periaqueductal gray, locus coeruleus or rostral ventromedial medulla of rats
34. Species difference of site-selective glucuronidation of morphine
35. Effects of certain abused drugs on hemolysin forming cells
36. Time course and cellular localization of lipopolysaccharide-induced inducible nitric oxide synthase messenger RNA in the rat in vivo
37. Lipopolysaccharide treatment in-vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA
38. Morphine-induced decreases in in vivo antibody responses
39. The major medical complication of morphine-6-glucuronide addiction
40. Endocarditis in "main line" opium addicts
41. Morphine-induced alterations of immune status: Dose-depencency, compartment specificity and antagonism by naltrexone
42. Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status
43. Endogenous opioids regulate the expression of inducible nitric oxide synthase by splenocytes
44. Heroin modulates the expression of inducible nitric oxide synthase
45. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide syntase
46. Alteration of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts: In vivo evidence for opiate receptor sites on T lymphocytes
47. Nitric oxide induced poly(ADP-ribose) polymerase cleavage in RAW264.7 macrophage apoptosis is blocked by Bcl-2
48. Decreased natural and antibody-dependent cellular cytotoxic activities in intravenous drug users
49. Involvement of central μbut not δ- or κ-opioid receptors in immunomodulation
50. Natural killer cell activity and lymphocyte subsets in parenteral morphine-6-glucuronide abusers and long-term methadone maintenance patients
51. In vitro studies of the effects of methadone on natural killer cell activity
52. Metabolism of drugs: LXIX studies on the urinary metabolites of morphine in several mammalian species
53. Nitric oxide mediates immune dysfunction in the spontaneously hypertensive rat
54. Morphine-6-glucuronide, a potent mu agonist
55. The metabolite morphine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function
56. Apoptosis in resolution of inflammation
57. Involvement of brain opiate receptors in the immune-suppressive effect of morphine
58. Morphine enhances macrophage apoptosis
59. The spinal antinociceptive actions of morphine metabolites morphine-6-glucuronide and normorphine in the rat
60. Alterations in nitric oxide production in various forms of circulatory shock
61. The intravenous administration of tumor necrosis factor alpha, interleukin 8 and macrophage-derived neutrophil chemotactic factor inhibits neutrophil migration by stimulating nitric oxide production
62. Immunomodulatory effects of in vitro exposure to morphine and its metabolites
63. Nitric oxide-mediated cytostatic activity on Trypanosoma brucei gambiense and Trypanosoma brucei brucei
64. Human brain metabolism of morphine and naloxone
65. Altered immune responses in mice lacking inducible nitric oxide synthase
66. Isolation and identification of morphine 3- and 6-glucuronides, morphine 3,6-diglucuronide, morphine 3-ethereal sulfate, nor-morphine, and normorphine 6-glucuronide as morphine metabolites in humans
67. Glucuronidation of morphine in human kidney microsomes